The Plasma Assays Market To Be Consistent In The Next 10 Years

Posted by Merin John on May 26th, 2021

Plasma assay is an investigating procedure to analyse the blood sample.The plasma assay is used to detect the infectious agents, cardiovascular diseases, diabetes, cancer biomarkers, drug abuse, protein, lipid, glucose level and other infectious agents that would cause severe chronic disease in future. A plasma assay is performed for various indications, such as anaemia, infection, leukaemia, hypokalemia, and kidney.

The COVID-19 outbreak has put tremendous pressure on healthcare services. Despite lockdown and disruption in the supply chain, the COVID 19 pandemic has encouraged the major market players to focus on research and development of various advanced testing technologies. For instance, in May 2020, the DarioHealth Corp. announced the FDA approval for the use of self-test plasma glucose meters by the diabetes patients in the hospitals. These meters were intended to limit the exposure to the COVID 19 viral infection, by self-diagnosing the blood-glucose levels.

Globally, the plasma assays market is primarily driven by increasing prevalence of chronic diseases like cardiovascular disease, and diabetes. Public awareness related to the complications concerned with chronic diseases and early diagnosisis the major factors that fuel the plasma assays market growth. Conversely, the rising focus on research activities and advancement for the early detection of infectious agents in plasma is expected to render lucrative opportunities during the forecast period.The costs of handling the equipment for plasma assay may restrain the plasma market growth during the forecast.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32459

Some key players operating in the plasma assays market are:

  •          Abbott Diagnostics
  •          Roche Diagnostics
  •          Danaher Corporation
  •          Bio-Rad Laboratories Inc.
  •          Quest Diagnostics
  •          Thermo Fisher Scientific Inc.
  •          Biomerica Inc.
  •          Becton Dickinson & Company
  •          BioMerieux S.A.
  •          Siemens Healthcare
  •          Trinity Biotech PLC
  •          Others

The glucose testing segment accounted higher share in the plasma assays market owing to the rising prevalence of chronic disease like diabetes among the growing population including adults as well as the children and increasing awareness among the people. Rising demand towards the advanced technology and point of care service with advance treatment witnessed the automated plasma assay method to dominate the plasma assays market in terms of methods used for the plasma detection during the forecast period. Diagnostic centres segment is projected tohold the largest share in the plasma assays market owing to the increasing preference towards testing the accuracy of laboratory tests and diminished turnaround time expects the diagnostic centres to surge the plasma assays market during the forecast period.

Like it? Share it!


Merin John

About the Author

Merin John
Joined: December 11th, 2020
Articles Posted: 262

More by this author